Loading...
Loading...
Among the 5 tracked institutional investors we monitor, RNTX (REIN THERAPEUTICS INC) is held with a combined value of $7.28M across 5,723,101 shares. The largest holder is Voss Capital, LP with a position worth $5.70M (0.30% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 3 funds increased their holdings.
Total Institutional Value
$7.28M
Total Shares Held
5,723,101
Institutional Holders
5
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | Voss Capital, LP | $5.70M | 0.30% | +3.4% |
| 2 | VANGUARD GROUP INC | $1.35M | 0.00% | New |
| 3 | STATE STREET CORP | $98.67K | 0.00% | - |
| 4 | BlackRock, Inc. | $89.09K | 0.00% | +24.6% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | $31.85K | 0.00% | +7.9% |
As of the latest SEC 13F filings, Voss Capital, LP is the largest institutional holder of RNTX with a position worth $5.70M, representing 0.30% of their portfolio. In total, 5 institutional investors hold RNTX with a combined value of $7.28M.
In the most recent quarter, 1 fund opened a new position in RNTX. Additionally, 3 increased their holdings.
Institutional investors hold $7.28M worth of RNTX stock across 5 positions. The largest institutional holder is Voss Capital, LP with $5.70M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For RNTX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their RNTX positions.